Status:
COMPLETED
Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Pertussis/Whooping Cough
Influenza Viral Infections
Eligibility:
FEMALE
18+ years
Brief Summary
Pertussis is a bacterial respiratory infection caused by Bordetella pertussis. Highly contagious, it is potentially serious and even fatal in infants under 6 months of age. The immunity acquired throu...
Eligibility Criteria
Inclusion
- Person having received complete information about the research and not opposed to the study.
- Hospitalization in the post-partum service and within the last 5 days of delivery.
- women. caregivers
Exclusion
- Female under 18 years of age,
- Woman under legal protection,
- Delivery of a stillborn child,
- Premature delivery \< 35GA,
- Hospitalized newborn,
- Women who doesn't speak french.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT05234229
Start Date
March 1 2022
End Date
October 30 2023
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternite Regionale Universitaire CHRU NANCY
Nancy, Lorraine, France, 54035